Ozempic and Wegovy: stopping treatment increases the risk of stroke by 22%

Une vaste étude américaine révèle qu'interrompre les traitements GLP-1 comme l'Ozempic augmente de 22% le risque…

Novo Nordisk revolutionizes the fight against obesity with oral treatment

The Danish pharmaceutical giant takes a new major step in the field of treatments against obesity.…